Akèy › Anplwayè › Tacere Therapeutics, Inc.
Tacere Therapeutics, Inc.: Salè H-1B ak pajon
Tacere Therapeutics, Inc. depoze 6 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 6. Medyèn salè yo ofri a: $142,186.
Èske Tacere Therapeutics, Inc. pajone visa H-1B?
Tacere Therapeutics, Inc. depoze 6 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Apr 2, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Scientist II | 2 | $142,186 |
| Senior Research Associate II | 1 | $112,422 |
| Chief Financial Officer | 1 | $531,900 |
| Financial Planning and Analysis Associate | 1 | $135,000 |
| Associate Director | 1 | $194,202 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 1 | $140,595 |
| FY2024 | 1 | $112,422 |
| FY2025 | 1 | $531,900 |
| FY2026 | 3 | $143,777 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Scientist II | $143,777 Nivo III | Hayward, CA | Apr 2, 2026 | Oct 1, 2026 | Certifye |
| Associate Director | $194,202 Nivo IV | Hawyward, CA | Apr 2, 2026 | Oct 1, 2026 | Certifye |
| Financial Planning and Analysis Associate | $135,000 Nivo III | West Hollywood, CA | Nov 3, 2025 | Nov 12, 2025 | Certifye |
| Chief Financial Officer | $531,900 E-3 · Nivo IV | Los Angeles, CA | Jan 28, 2025 | Mar 1, 2025 | Certifye |
| Senior Research Associate II | $112,422 Nivo II | Hayward, CA | Apr 15, 2024 | Oct 1, 2024 | Certifye |
| Scientist II | $140,595 Nivo IV | Hayward, CA | Apr 3, 2023 | Oct 1, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).